Education
About Us
Working with TipRanks
Follow Us
Tandem Diabetes Care (TNDM)
NASDAQ:TNDM
Earnings Data
Report Date
Oct 29, 2025After Close (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
-0.33Last Year’s EPS
-0.35Same Quarter Last Year
Moderate Buy
Based on 20 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call showcased Tandem Diabetes Care's strong performance with record sales and significant progress in pharmacy channel expansion and international markets. However, there are challenges such as moderate U.S. sales growth and increased competition affecting the future outlook.Company Guidance
Record Second Quarter Sales
Tandem Diabetes Care achieved record second quarter sales, both in the U.S. and internationally, with worldwide sales of $241 million, marking the highest second quarter sales in both markets.
Strong Pump Shipments and Renewals
There was a year-over-year increase in pump shipments in the U.S., with renewals accounting for over half of the shipments, demonstrating strong retention and continued double-digit growth in renewals.
Pharmacy Channel Expansion
Progress in pharmacy channel expansion with plans to start selling t:slim supplies through the pharmacy channel beginning in Q4, aimed at making pump therapy more affordable and lowering out-of-pocket costs for patients.
International Market Growth
Strong performance in international markets with $70 million in sales, driven by demand for t:slim, increasing pump renewals, and growing supply sales.
Gross Margin Improvement
Achieved a gross margin of 52%, reflecting an increase year-over-year and compared to the first quarter, driven by pricing improvements and operational goals.
Product Development Milestones
Significant product development milestones achieved in Q2, including the Tandem Mobi's positive feedback and the upcoming integration with Abbott's FreeStyle Libre 3 Plus sensor.
TNDM Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
TNDM Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 06, 2025 | $14.39 | $11.52 | -19.94% |
Apr 30, 2025 | $16.85 | $19.98 | +18.58% |
Feb 26, 2025 | $33.59 | $21.75 | -35.25% |
Nov 06, 2024 | $34.24 | $33.32 | -2.69% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Tandem Diabetes Care (TNDM) report earnings?
Tandem Diabetes Care (TNDM) is schdueled to report earning on Oct 29, 2025, After Close (Confirmed).
What is Tandem Diabetes Care (TNDM) earnings time?
Tandem Diabetes Care (TNDM) earnings time is at Oct 29, 2025, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TNDM EPS forecast?
TNDM EPS forecast for the fiscal quarter 2025 (Q3) is -0.33.
